Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
© 2024 FinOracle.net - Your financial oracle, analytics and forecasts for stocks, cryptocurrency.